Novartis partners with U of Penn on CAR T Cell Immunotherapy

Anonymous

CAR T Cell Immunotherapy is one of the most promising new cancer treatments.

University of Pennsylvania has signed a partnership agreement with Novartis to expand

CAR T Cell Immunotherapy. Dr Carl June and his team lead this research.

They are hoping to use this treatment soon for solid tumors as well.

http://articles.philly.com/2012-08-06/news/33066220_1_cancer-cells-tumor-lysis-syndrome-novartis

http://www.bloomberg.com/news/2012-08-06/novartis-gets-immune-cell-cancer-therapy-in-upenn-pact.html

http://blogs.nature.com/news/2012/08/novartis-gives-upenn-20-million-for-cancer-vaccine.html